1. Home
  2. CYTK vs ADT Comparison

CYTK vs ADT Comparison

Compare CYTK & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ADT
  • Stock Information
  • Founded
  • CYTK 1997
  • ADT 1874
  • Country
  • CYTK United States
  • ADT United States
  • Employees
  • CYTK 564
  • ADT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ADT Diversified Commercial Services
  • Sector
  • CYTK Health Care
  • ADT Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • ADT Nasdaq
  • Market Cap
  • CYTK 5.8B
  • ADT 6.7B
  • IPO Year
  • CYTK 2004
  • ADT 2018
  • Fundamental
  • Price
  • CYTK $48.87
  • ADT $6.82
  • Analyst Decision
  • CYTK Buy
  • ADT Hold
  • Analyst Count
  • CYTK 16
  • ADT 4
  • Target Price
  • CYTK $84.07
  • ADT $8.55
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • ADT 5.3M
  • Earning Date
  • CYTK 11-06-2024
  • ADT 10-24-2024
  • Dividend Yield
  • CYTK N/A
  • ADT 3.22%
  • EPS Growth
  • CYTK N/A
  • ADT 2041.84
  • EPS
  • CYTK N/A
  • ADT 0.98
  • Revenue
  • CYTK $3,219,000.00
  • ADT $5,140,300,000.00
  • Revenue This Year
  • CYTK N/A
  • ADT N/A
  • Revenue Next Year
  • CYTK $795.25
  • ADT $4.27
  • P/E Ratio
  • CYTK N/A
  • ADT $6.91
  • Revenue Growth
  • CYTK N/A
  • ADT 7.14
  • 52 Week Low
  • CYTK $43.21
  • ADT $6.02
  • 52 Week High
  • CYTK $110.25
  • ADT $8.25
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • ADT 27.50
  • Support Level
  • CYTK $45.66
  • ADT $6.76
  • Resistance Level
  • CYTK $49.40
  • ADT $7.48
  • Average True Range (ATR)
  • CYTK 1.71
  • ADT 0.17
  • MACD
  • CYTK -0.20
  • ADT -0.08
  • Stochastic Oscillator
  • CYTK 50.79
  • ADT 6.70

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ADT ADT Inc.

ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.

Share on Social Networks: